{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T19:51:10Z","timestamp":1781207470604,"version":"3.54.1"},"reference-count":15,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"internal grants"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Around 0.5\u20131% of the world population is suffering from cachexia. In particular, cancer patients under cancer radio-chemotherapy have a high prevalence of cachexia, especially during the end stages of therapeutic treatment. Clinically, chemotherapeutic 5-fluorouracil (5-Fu) treatment often leads to the development of adverse effects, such as leukopenia, immune dysfunction, anorexia, muscle wasting, etc., and 5-Fu also tends to exacerbate the occurrence of cancer cachexia. Currently, there are very limited drug choices when seeking to revive cachexia patient\u2019s health quality while enduring a full therapeutic regimen as part of advanced cancer therapy. The present study employed chemotherapeutic drug 5-Fu-induced cachexia-like conditions in Balb\/c mice. After 8 days of 5-Fu treatment, mice had begun to show cachexia-like symptoms such as weight loss and reduced food intake. After one day of washing out, the cachexia animals received a single dose of either saline solution as a mock dose or a low dose (15 mg\/kg BW) or high dose (30 mg\/kg BW) of ketamine at day 10. For the following 7 days, food intake, body weight, and mortality were monitored. Data were analyzed with the LOCF (last observation carried forward) method. Improved survival rates were obtained in ketamine groups. Ketamine administration at the high dose of 30 mg\/kg BW demonstrated effectively diminished weight loss due to cachexia, and also successfully improved overall survival. The current study demonstrates that a sub-anesthetic level of ketamine administration supports overall beneficial outcomes in 5-Fu-induced cachexia and outlook as a potential clinical remedy.<\/jats:p>","DOI":"10.3390\/life13010008","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T02:58:27Z","timestamp":1671591507000},"page":"8","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A Pre-Clinical Study of Sub-Anesthetic Ketamine as Remedy in 5-Fluorouracil-Induced Cachexia Model"],"prefix":"10.3390","volume":"13","author":[{"given":"James","family":"Wang","sequence":"first","affiliation":[{"name":"Astromedical Biotechnology, LLC, New Taipei City 25147, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zen-Cheng","family":"Lin","sequence":"additional","affiliation":[{"name":"Astromedical Biotechnology, LLC, New Taipei City 25147, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8994-4750","authenticated-orcid":false,"given":"Brian Bor-Chun","family":"Weng","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology, and Biopharmaceuticals, College of Life Sciences, National Chiayi University, Chiayi 60004, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s13539-014-0164-8","article-title":"Prevalence, Incidence and Clinical Impact of Cachexia: Facts and Numbers-Update 2014","volume":"5","author":"Anker","year":"2014","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1002\/jcsm.12776","article-title":"Prevalence and Prognostic Impact of Cachexia among Older Patients with Cancer: A Nationwide Cross-Sectional Survey (NutriAgeCancer)","volume":"12","author":"Poisson","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/rco2.50","article-title":"Mechanisms of Chemotherapy-Induced Muscle Wasting in Mice with Cancer Cachexia","volume":"5","author":"Murphy","year":"2022","journal-title":"JCSM Rapid Commun."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"7535","DOI":"10.1038\/s41598-020-64282-z","article-title":"An Elevated Neutrophil-to-Lymphocyte Ratio Associates with Weight Loss and Cachexia in Cancer","volume":"10","author":"Campelj","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Farhang-Sardroodi, S., la Croix, M.A., and Wilkie, K.P. (2022). Chemotherapy-Induced Cachexia and Model-Informed Dosing to Preserve Lean Mass in Cancer Treatment. PLoS Comput. Biol., 18.","DOI":"10.1371\/journal.pcbi.1009505"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2147\/TCRM.S196802","article-title":"Emerging Treatment Options For Cancer-Associated Cachexia: A Literature Review","volume":"15","author":"Naito","year":"2019","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/mp.2017.255","article-title":"Mechanisms of Ketamine Action as an Antidepressant","volume":"23","author":"Zanos","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/bja\/aem218","article-title":"Low-Dose Ketamine Affects Immune Responses in Humans during the Early Postoperative Period","volume":"99","author":"Beilin","year":"2007","journal-title":"Br. J. Anaesth."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.aat.2012.12.001","article-title":"Mechanisms of Ketamine-Induced Immunosuppression","volume":"50","author":"Liu","year":"2012","journal-title":"Acta Anaesthesiol. Taiwanica"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00000539-200001000-00041","article-title":"Ketamine Modulates the Stimulated Adhesion Molecule Expression on Human Neutrophils in Vitro","volume":"90","author":"Weigand","year":"2000","journal-title":"Anesth. Analg."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/jcsm.12360","article-title":"Cachexia Induced by Cancer and Chemotherapy Yield Distinct Perturbations to Energy Metabolism","volume":"10","author":"Pin","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.biopsych.2013.04.027","article-title":"Repeated Ketamine Exposure Induces an Enduring Resilient Phenotype in Adolescent and Adult Rats","volume":"74","author":"Parise","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41586-022-04993-7","article-title":"Dual Action of Ketamine Confines Addiction Liability","volume":"608","author":"Simmler","year":"2022","journal-title":"Nature"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/eat.22937","article-title":"Single Injection of Ketamine during Mid-Adolescence Promotes Long-Lasting Resilience to Activity-Based Anorexia of Female Mice by Increasing Food Intake and Attenuating Hyperactivity as Well as Anxiety-like Behavior","volume":"51","author":"Chen","year":"2018","journal-title":"Int. J. Eat. Disord."},{"key":"ref_15","first-page":"252","article-title":"The Immunomodulatory Effect of Ketamine in Depression","volume":"31","author":"Alisowska","year":"2019","journal-title":"Psychiatr. Danub."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/1\/8\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:44:51Z","timestamp":1760147091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/13\/1\/8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,20]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["life13010008"],"URL":"https:\/\/doi.org\/10.3390\/life13010008","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,20]]}}}